- Report
- December 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2024
- 103 Pages
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 80 Pages
North America
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 82 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 93 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- January 2024
- 77 Pages
Middle East, Africa
From €3140EUR$3,450USD£2,692GBP
- Report
- March 2024
- 322 Pages
United States
From €7276EUR$7,995USD£6,238GBP
- Report
- March 2023
- 47 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Report
- March 2023
- 648 Pages
Global
From €9096EUR$9,995USD£7,798GBP
- Report
- January 2024
- 77 Pages
Global
From €3500EUR$4,120USD£3,106GBP
The Cerebrospinal Fluid (CSF) Shunt market is a subset of the larger Neurology Devices market. CSF shunts are medical devices used to treat hydrocephalus, a condition in which excess cerebrospinal fluid accumulates in the brain. The shunt is surgically implanted and diverts the excess fluid from the brain to another area of the body, such as the abdomen, where it can be absorbed. CSF shunts are typically made of a flexible tube with a valve that regulates the flow of fluid.
The CSF Shunt market is highly competitive, with a variety of companies offering a range of products. Companies in the market include Medtronic, Integra LifeSciences, DePuy Synthes, Natus Medical, and B. Braun. These companies offer a range of products, including ventriculoperitoneal shunts, lumboperitoneal shunts, and ventriculoatrial shunts. Show Less Read more